Grant✓ Small businesses may apply
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health
Award ceiling
$750,000
Program funding
$750,000
- Opportunity #
- PAR-25-059
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.853
- Status
- posted
- Posted
- Oct 22, 2024
- Closes
- Oct 20, 2027
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •Special district governments
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •State governments
- •Public and State controlled institutions of higher education
- •Public housing authorities/Indian housing authorities
- •Private institutions of higher education
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •City or township governments
- •For profit organizations other than small businesses
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •County governments
- •Independent school districts
- •Native American tribal governments (Federally recognized)
- •Small businesses
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Synopsis
This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs.
Contact
National Institutes of Health · grantsinfo@nih.gov